A Randomized Non-Inferiority Clinical Trial of Doxycyline Vs BPG for Early Syphilis

Trial Information
Status: Not yet recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
Summary

According to European and US Centers for Disease Control and Prevention (CDC) guidelines, the recommended treatment for uncomplicated early syphilis in adults (i.e. primary, secondary and early latent) is a single intramuscular injection of 2.4 million units of benzathine benzylpenicillin G (BPG). Recent reviews have also recommended BPG as the first-line treatment of early syphilis, reporting a success rate of more than 90% over a large panel of studies. This form of the drug provides weeks of treponemicidal levels of penicillin in the blood, but does not efficiently cross the blood-brain barrier.

Am I eligible for this trial?
Where is this trial taking place?
Who do I contact about this trial?
When is this trial taking place?
How many participants will be in this trial?
What treatment is being studied in this trial?
Who are the authors of this trial?
What other conditions are being studied in this trial?

This content was sourced from clinicaltrials.gov